MindWalk Holdings (HYFT) Gross Margin (2020 - 2026)

MindWalk Holdings (HYFT) reported Gross Margin of 0.0% for Q1 2026, down 6455.0% year-over-year from 0.0% in Q1 2025, and down 100.0% quarter-over-quarter from 64548.98% in Q4 2025.

MindWalk Holdings (HYFT) Gross Margin (2020 - 2026) Analysis & Trends

MindWalk Holdings (HYFT) has 7 years of Gross Margin data on file, last reported at 0.0% in Q1 2026.

  • Gross Margin for Q1 2026 came in at 0.0%, down 6455.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.21% (down 5224.0% YoY), and the FY2025 annual result was 55.25%, up 609.0% from the prior year.
  • Gross Margin eased to 0.0% in Q1 2026 per HYFT's latest filing, from 64548.98% in the prior quarter.
  • Over five years, Gross Margin peaked at 73977154.72% in Q1 2022 and troughed at 0.0% in Q1 2026.
  • A 5-year average of 4355438.6% and a median of 53.44% in 2022 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin soared 2000000000 bps in 2022, then tumbled 2000000000 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 53.61% in 2022, then fell by 10 bps to 48.03% in 2023, then advanced by 6 bps to 51.1% in 2024, then surged by 126216 bps to 64548.98% in 2025, then slumped by 100 bps to 0.0% in 2026.
  • Business Quant data shows HYFT's Gross Margin at 0.0% in Q1 2026, 64548.98% in Q4 2025, and 48.31% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 86.85%
9 Abivax 94.26 Bn 94.26 Bn - -
10 MindWalk Holdings 166.20 Mn 156.06 Mn 1.78 0.00%

Historic Data

Download Data
DateValue
Jan 31, 2026 0.00%
Oct 31, 2025 64,548.98%
Jul 31, 2025 48.31%
Apr 30, 2025 63.89%
Jan 31, 2025 64.55%
Oct 31, 2024 51.10%
Jul 31, 2024 40.84%
Apr 30, 2024 48.12%
Jan 31, 2024 51.39%
Oct 31, 2023 48.03%
Jul 31, 2023 49.14%
Apr 30, 2023 59.44%
Jan 31, 2023 57.32%
Oct 31, 2022 53.61%
Jul 31, 2022 53.44%
Apr 30, 2022 63.29%
Jan 31, 2022 73,977,154.72%
Oct 31, 2021 58.65%
Jul 31, 2021 54.62%
Apr 30, 2021 56.94%